Investors - Press Releases
Tabula Rasa HealthCare Expands MedWise® Technology Offerings to Key Markets
Through these agreements the combined MTM / EMTM program will be used to enhance a national Medication MTM program and a regional Blue's traditional Medicare MTM program.
Medication problems resulting from dangerous drug interactions are a major cause of hospitalization and death in the
Applying TRHC's propriety MedWise technology to traditional MTM programs will permit providers and insurers to more accurately target patients who may be at high risk for ADEs, reducing costs and improving patient care. These patients can then receive Medication Safety Reviews™, which will further illuminate multi-drug interactions and offer interventions to enhance medication safety.
"Research has clearly demonstrated the ability of our MedWise technology to identify individuals at higher risk of ADEs," said TRHC Chairman and CEO
Peer-reviewed, published studies have found that a lower MedWise Risk Score™, correlated with fewer ADEs, emergency department visits, and hospitalizations; lower medical costs; and a decreased risk of premature death.
To learn more about TRHC and its offerings, visit us online here.
View original content to download multimedia:https://www.prnewswire.com/news-releases/tabula-rasa-healthcare-expands-medwise-technology-offerings-to-key-markets-301357099.html
Anthony Mirenda, firstname.lastname@example.org